Results 131 to 140 of about 149,842 (242)

Pengaruh Jus Buah Manggis (Garcinia Mangostana L.) Terhadap Profil Farmakokinetik Parasetamol Pada Tikus Putih Jantan (Rattus Norvegicus) Galur Wistar [PDF]

open access: yes, 2013
Drug interaction happen when drugs is given together with foods. This researchwas aimed to observe the effect of mangosteen juice to the paracetamol pharmacokineticprofile in Wistar male white rats.
Oktaviani, E. (Emy)
core   +1 more source

Plasma Adsorption Perfusion (BR‐350) Versus Open Albumin Dialysis (OPAL) for Hyperbilirubinemia in Hepatic Failure in Cirrhotic Patients

open access: yesArtificial Organs, EarlyView.
The therapy with PAP using BR‐350 resulted in a significant decrease of bilirubin concentrations. The median relative reduction of bilirubin was comparable between PAP and OPAL (47% vs. 40%, p = 0.29). The crossover comparison between the single session of PAP using BR‐350 and OPAL revealed similar relative reduction rates of bilirubin.
Justa Friebus‐Kardash   +8 more
wiley   +1 more source

Human Milk Practices in Swedish Neonatal Units: Results From a Nationwide Survey

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim The aim of this study was to describe the routines for handling mother's own milk and donor human milk in Swedish neonatal care units related to national guidelines. Methods A web‐based survey of 24 of 38 neonatal units and 19 of 28 human milk banks in Sweden. Results Despite national guidelines, breast milk handling varied widely.
Ylva Thernström Blomqvist   +7 more
wiley   +1 more source

Therapy after therapy: Entry rates into subsequent psychological treatment among patients receiving therapist‐guided internet‐delivered or face‐to‐face psychotherapy

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Objectives Despite numerous psychotherapy trials, knowledge on service‐system efficiency in terms of return to treatment is limited, especially regarding internet‐delivered cognitive behavioural therapy (iCBT). We estimated the hazard ratio (HR) of subsequent psychological treatment over several years following the initial psychological ...
A. Plattonen   +3 more
wiley   +1 more source

Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial

open access: yesBJU International, Volume 135, Issue 4, Page 638-647, April 2025.
Objectives To evaluate the effect of intravesical alkalinised lidocaine as an anaesthetic treatment on procedural pain during intradetrusor onabotulinumtoxinA (BTX‐A) injections for overactive bladder. Patients and Methods This single‐centre, randomised, double‐blind, placebo‐controlled two period crossover trial was conducted on women scheduled for ...
Meryam El Issaoui   +2 more
wiley   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman   +3 more
wiley   +1 more source

Paracetamol in Pregnancy: Reassurance Amidst Uncertainty. [PDF]

open access: yesBJOG
BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 5, Page 877-883, April 2026.
Samara A, Khalil A.
europepmc   +2 more sources

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy